1 / 13

Edo Agustian Indonesian Drug Users Network kornas@pkni

Hepatitis C among people who inject drugs in Indonesia : An urgent public health crisis. Edo Agustian Indonesian Drug Users Network kornas@pkni.org HCV and PWID in Asia Strategies for Treatment Scale up. Outline of Presentation.

ona
Télécharger la présentation

Edo Agustian Indonesian Drug Users Network kornas@pkni

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Hepatitis C among people who inject drugs in Indonesia : An urgent public health crisis • Edo Agustian • Indonesian Drug Users Network • kornas@pkni.org • HCV and PWID in Asia Strategies for Treatment Scale up

  2. Outline of Presentation • Overview of hepatitis C among people who inject drugs in Indonesia • Indonesia’s national response • Barriers to testing and treatment access • Advocacy and community engagement

  3. Viral Hepatitis in Indonesia

  4. The national response to the prevention, treatment and management ofhepatitis C among people who inject drugs • Late response, fragmented • Indonesia does not conduct routine national surveillance • There is no national clinical guideline for diagnosis, treatment and care for HCV • The Ministry of Health first established a national program focused on viral hepatitis in 2011, under the Sub Directorate for Gastrointestinal Infections and Diarrheal Diseases.

  5. Monitoring of the quality of harm reduction programs in 9 provinces by the drug user community

  6. Advocacy and community engagement Since 2011, PKNI has worked with drug users, policy-makers, and service providers to raise awareness about Hep C and ensure that the community is meaningfully involved in the national response. Highlights include: • Fill pre grant opposition against Sofosbufir patent registration • Training of service providers across 9 provinces • Collaboration with Indonesian Liver Researchers Association and Ministry of health on public Hep C campaign • Policy briefing on Hep C • Hepatitis C Community Task Force to input in MoH planning • Treatment price reductions and pharma advocacy • Involved in developing National Guideline for Hep C Care, Support and Treatment with MoH in 2014

More Related